Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Sees FY 2013 Revenue Guidance To A Slightly Lower Midpoint Of Prior Range; Reaffirms FY 2013 EPS Guidance-Conference Call


Thursday, 10 Jan 2013 09:00pm EST 

Angiodynamics Inc announced that for fiscal 2013, it guide to a slightly lower midpoint, from 5% down to 4%, on revenue at $358 million. The Company did not change earnings per share (EPS) and are still guiding to $0.40 to $0.42. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $356 million, and EPS of $0.40 for fiscal 2013. 

Company Quote

13.96
 +0.00%
29 Aug 2014